Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Molecular diagnostics company XDx has filed an Inter Partes Reexamination requesting the US Patent and Trademark Office to review certain claims of US patent assigned to Source MDx.
Subscribe to our email newsletter
The patent purports to claim methods for creating an index of a subject’s biological state pertaining to inflammation. XDx’s request states that a combination of prior art references available before the this patent’s earliest priority date raise substantial new questions about the patentability of certain of the patent’s claims.